Aceto (ACET) Releases Quarterly Earnings Results
Aceto (NASDAQ:ACET) posted its quarterly earnings results on Thursday. The company reported $0.21 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.17 by $0.04, American Banking News.com reports. The company had revenue of $139.60 million for the quarter, compared to the consensus estimate of $134.23 million. During the same quarter in the prior year, the company posted $0.20 earnings per share.
Aceto (NASDAQ:ACET) traded down 0.05% on Thursday, hitting $19.60. The stock had a trading volume of 213,145 shares. Aceto has a 52 week low of $14.28 and a 52 week high of $25.25. The stock has a 50-day moving average of $18.16 and a 200-day moving average of $18.84. The company has a market cap of $563.1 million and a P/E ratio of 19.38.
The company also recently declared a quarterly dividend, which is scheduled for Monday, September 29th. Investors of record on Monday, September 15th will be given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 1.22%.
In other Aceto news, Chairman Albert L. Eilender unloaded 7,144 shares of Aceto stock on the open market in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $19.14, for a total value of $136,736.16. The sale was disclosed in a document filed with the SEC, which is available at this link.
Aceto Corporation (NASDAQ:ACET) is primarily engaged in the sourcing, regulatory support, quality assurance, marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical consuming industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.